Our results supported that FOXO1 can alleviate the microenvironmental disturbance and reverse Th17/Treg cells imbalance, thus having a certain effect on relieving IRI-induced HCC recurrence. The gene discussed is FOXO1; the disease is hepatocellular carcinoma.